TY  - JOUR

T1  - Specifically Targeting Interleukin-13 with Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients with Atopic Dermatitis

JO  - SKIN The Journal of Cutaneous Medicine

PY  - 2021/01/01

AU  - Silverberg J

AU  - Barbarot S

AU  - Gooderham M

AU  - Simon J

AU  - Simpson E

AU  - Kurbasic A

AU  - Olsen C

AU  - Cork M

ED  - 

DO  - DOI: 10.25251/skin.5.supp.9

PB  - National Society for Cutaneous Medicine

VL  - 5

IS  - 1

SP  - s9

EP  - s9

Y2  - 2024/12/22

ER  -